Company Overview
- Website
 - nuclein.com
 
- Employees
 - 25
 
- Industry
 - BioTech/Drugs
 
- SIC Code
 - 
                                8731 - Commercial Physical and Biological Research
 
Financials & Stats
Revenue
$10B
Recent News & Media
Nucleic acid - Methylation, DNA, RNA
- Jun 11, 2025
 - britannica.com
 
Trinity Investors Celebrates Nuclein’s Dual FDA Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test
- Jan 8, 2025
 - globenewswire.com
 
Nuclein's DASH® SARS-CoV-2 & Flu A/B Test for Use on the DASH® Rapid PCR System Receives FDA 510(k) Clearance and CLIA Waiver with Key Support from CovarsaDx® Research Team
- Jan 7, 2025
 - biospace.com
 
Nuclein Receives Dual FDA 510(k) Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test for use on the DASH® Rapid PCR System
- Jan 6, 2025
 - prnewswire.com
 
These are the 8 best startups to watch for in Austin, according to LinkedIn data
- Nov 4, 2024
 - statesman.com
 
Friedrich Miescher (portrait in a) isolated “nuclein” as shown in an...
- Oct 22, 2023
 - researchgate.net
 
Company Leadership
Companies Similar to Nuclein
Analyze industry trends and opportunities by examining competitors and companies comparable to Nuclein, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in | 
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |